Ethylene Glycol

Ethylene Glycol

SCHEMBL5137218

CCCCCCCCC(CCCCCC)CC(=O)O.OCCO

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 11/20 0.60
LMNA P02545 1/20 0.54
FFAR1 O14842 3/20 0.48
FFAR4 Q5NUL3 2/20 0.48
PPARD Q03181 7/20 0.47
MAPT P10636 1/20 0.47
LCK P06239 1/20 0.47
ZDHHC20 Q5W0Z9 1/20 0.47
ZDHHC2 Q9UIJ5 1/20 0.47
PPARG P37231 6/20 0.45
PPARA Q07869 6/20 0.45
HDAC11 Q96DB2 5/20 0.45
TSHR P16473 4/20 0.45
ALDH1A1 P00352 2/20 0.45
TLR2 O60603 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
FABP4 P15090 2/20 0.45
PTPN1 P18031 2/20 0.45
SLC22A6 Q4U2R8 1/20 0.45
SLC22A8 Q8TCC7 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene Glycol SCHEMBL5137927 1.00 GPR84 (0.60) GPR84LMNAFFAR1FFAR4PPARD
Ethylene Glycol SCHEMBL5138346 1.00 GPR84 (0.60) GPR84LMNAFFAR1FFAR4PPARD
Ethylene Glycol SCHEMBL5136577 1.00 GPR84 (0.60) GPR84LMNAFFAR1FFAR4PPARD
SCHEMBL7202803 0.94 GPR84 (0.58) GPR84LMNAFFAR1FFAR4PPARD
1,6-Hexanediol SCHEMBL5137145 0.94 GPR84 (0.58) GPR84LMNAFFAR1FFAR4PPARD
1,6-Hexanediol SCHEMBL5137134 0.94 GPR84 (0.58) GPR84LMNAFFAR1FFAR4PPARD
1,6-Hexanediol SCHEMBL5137115 0.94 GPR84 (0.58) GPR84LMNAFFAR1FFAR4PPARD
SCHEMBL8991255 0.94 GPR84 (0.58) GPR84LMNAFFAR1FFAR4PPARD
SCHEMBL5171531 0.94 GPR84 (0.58) GPR84LMNAFFAR1FFAR4PPARD
1,6-Hexanediol SCHEMBL5137760 0.94 GPR84 (0.58) GPR84LMNAFFAR1FFAR4PPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7402610-B2 Carbonyl compound containing long-chain branched alkyl group IDEMITSU KOSAN CO., LTD. (JP) 2008-07-22 US disclosed
US-20070282123-A1 Carbonyl Compound Containing Long-Chain Branched Alkyl Group IDEMITSU KOSAN CO., LTD (JP) 2007-12-06 US disclosed
EP-1710225-A1 CARBONYL COMPOUND CONTAINING LONG-CHAIN BRANCHED ALKYL GROUP IDEMITSU KOSAN CO., LTD. (JP) 2006-10-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070282123-A1 Carbonyl Compound Containing Long-Chain Branched Alkyl Group HSD17B12, ALOX15, LSS GPR84 888/4885LMNA 273/4885FFAR1 631/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.